Molecular and Genetic Medicine

Muzyczka N

Biography

Dr. Nicholas Muzyczka, Ph.D., also known as Nick, Co-Founded Applied Genetic Technologies Corporation in 1999. As a fellow in Dan Nathans laboratory, Dr. Muzyczka designed some of the earliest mammalian vectors based on SV40 virus. He subsequently developed the first AAV vectors and has been a leader in the development of this vector technology. He has contributed both to the study of the basic biology of AAV, as well as its application to human diseases. His laboratory is currently the leader in studies of the biochemistry of AAV transcription, DNA replication, and packaging. He is also a leader in the use of AAV vectors for central nervous system therapy. Dr. Muzyczka served as a Director at Applied Genetic Technologies Corporation. Dr. Muzyczka received his B.S. in Biology at Antioch College and his Ph.D. in Biochemistry at Johns Hopkins University.

Research Interest

Moloecular biology, Genetics, Virology